| Literature DB >> 26583142 |
G Frazzitta1, F Bossio1, R Maestri2, G Palamara1, R Bera1, D Ferrazzoli1.
Abstract
Balance dysfunctions are a major challenge in the treatment of Parkinson's disease (PD). Previous studies have shown that rehabilitation can play a role in their treatment. In this study, we have compared the efficacy of two different devices for balance training: stabilometric platform and crossover. We have enrolled 60 PD patients randomly assigned to two groups. The first one (stabilometric group) performed a 4-week cycle of balance training, using the stabilometric platform, whereas the second one (crossover group) performed a 4-week cycle of balance training, using the crossover. The outcome measures used were Unified Parkinson's Disease Rating Scale (UPDRS) part II, Berg Balance Scale (BBS), Timed Up and Go (TUG), and Six Minutes Walking Test (6MWT). Results showed that TUG, BBS, and UPDRS II improved in both groups. There was not difference in the efficacy of the two balance treatments. Patients in both groups improved also the meters walked in the 6MWT at the end of rehabilitation, but the improvement was better for patients performing crossover training. Our results show that the crossover and the stabilometric platform have the same effect on balance dysfunction of Parkinsonian patients, while crossover gets better results on the walking capacity.Entities:
Mesh:
Year: 2015 PMID: 26583142 PMCID: PMC4637085 DOI: 10.1155/2015/878472
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Stabilometric platform.
Figure 2Crossover.
Figure 3Examples of the five “stabilometric track” exercises.
Figure 4The exercises on the platform increased in difficulty each week and were studied in order to progressively stress the patient's limit of stability. (a) Exercises performed on the 1st week. (b) Exercises performed on the 2nd week. (c) Exercises performed on the 3rd week. (d) Exercises performed on the 4th week.
Demographic characteristics and basal clinical data in both groups.
| Variable | Group 1 (stabilometric) | Group 2 (crossover) |
|
|---|---|---|---|
| Age | 66.6 (10.0) | 65.0 (8.8) | 0.500 |
| Sex (male/female) | 13/17 | 17/13 | 0.30 |
| Height (cm) | 165.7 (10.5) | 166.4 (8.6) | 0.76 |
| L DOPA eq | 608.7 (307.6) | 740.9 (297.8) | 0.059 |
| HY | 2.8 (0.4) | 2.8 (0.4) | 0.627 |
| UPDRS II | 15.1 (5.2) | 13.9 (4.4) | 0.313 |
| BBS | 45.5 (7.8) | 46.3 (5.1) | 0.917 |
| TUG | 12.5 (6.4) | 11.0 (3.5) | 0.337 |
| 6MWT | 319.3 (115.1) | 340.3 (87.3) | 0.333 |
Delta: value at discharge − baseline value (absolute effect size).
| Variable | Group 1 Delta | Group 2 Delta | Group effect | Time effect | Time × group interaction | |||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| BBS | 7.3 | 7.6 | 0.53 | 0.47 | 170 | <0.0001 | 0.05 | 0.82 |
| UPDRS II | −5.2 | −5.1 | 1.19 | 0.28 | 220 | <0.0001 | 0.04 | 0.85 |
| TUG | −3.3 | −3.0 | 2.12 | 0.15 | 42 | <0.0001 | 0.13 | 0.72 |
| 6MWT | 68.8 | 103.3 | 2.44 | 0.12 | 118 | <0.0001 | 4.7 | 0.0337 |